T cell activation involves positive cellular signals that promote effector functions and negative signals that contribute to the regulation of these responses. These regulatory signals are generated upon activation of receptors on T cells that include CD160, 2B4, Programmed Death-1 and CTLA-4. Objective. To evaluate the expression of inhibitory receptors like CD160, 2B4, Programmed Death-1 and CTLA-4 on CD4+ and CD8+ T cells from healthy Colombian donors. Materials and methods. Peripheral blood mononuclear cells from 30 healthy donors from Bogotá (Colombia) were obtained via Ficoll-Hypaque density gradient and cells were stained with specific conjugated antibodies previously titrated. Results. The CD160, 2B4, and Programmed Death-1 inhibitory markers were detected on CD4+ T cells with expression levels of 0.35%, 1.04%, and 1.35%, respectively. On CD8+ T cells, these markers were expressed at higher levels: 16%, 8.97%, and 4.3%, respectively. In contrast to the other receptors, CTLA-4 frequency of expression showed no significant difference between CD4+ (1.56%) and CD8+ (1.53%) T cells. Frequency of CD160/2B4 and CTLA-4/ Programmed Death-1 coexpression was 0.18% and 0.09% on CD4+ cells, and 4.02% and 0.2% on CD8+ T cells. Conclusions. This is the first report showing the frequency of inhibitory receptors such as CD160, 2B4, Programmed Death-1, and CTLA-4 on CD4+ and CD8+ T cells from healthy Colombian donors. Our findings serve as a baseline for the analysis and comparison of these receptors in Colombian populations with different disease conditions.
Introduction
The outcome of the immune response is largely defined by the predominant microenvironment at the moment of T cell activation. This activation, upon antigen recognition, involves signals that promote effector functions and negative signals that contribute to the regulation of cellular immune responses. In general, on T cells both signals are generated by the interaction of surface molecules with their ligands on antigen presenting cells (APCs) or soluble molecules in the microenvironment. Molecules like CD160, 2B4, Programmed Death-1 (PD-1), and Cytotoxic T-lymphocyte Antigen 4 (CTLA-4), have been identified as inductors of negative signals, which regulates the activation events of CD4+ and CD8+ T cells (1) .
In chronic infection, the phenomenon of T cell clonal exhaustion has been described as a progressive loss of effector functions. This process seems to be caused by antigen persistence and usually begins with the reduction of the proliferative potential, as well as a decrease in the production of interleukin 2 (IL)-2, followed by a reduction of tumor necrosis factor alpha (TNF-a) and gamma interferon (IFNg) production (2, 3). Of special interest, molecules that induce negative signals as a regulatory mechanism during the lymphocytic activation increase their expression on T cells entering in such a dysfunctional state. Moreover, the co-expression of two or more inhibitory receptors is associated to clonal exhaustion in both CD4+ and CD8+ T cells (4, 5) . Nonetheless, expression data of these molecules in T cells from clinically healthy individuals are scarce and limited to certain human populations.
As a previous step to studying the expression of these molecules in Colombian patients with chronic infections, tumors or autoimmune diseases, herein we evaluated the frequency of CD4+ and CD8+ T cells expressing inhibitory receptors like as CD160, 2B4, PD-1 and CTLA-4 in healthy Colombian donors.
Materials and methods

Study population
All individuals enrolled in the study were clinically healthy volunteers who signed the informed consent form. Thirty individuals from Bogotá (Colombia), 67% female and 33% male, between 25 and 46 years of age old were included. This study was approved by the Research and Ethics Committee of the School of Science at Pontificia Universidad Javeriana, Bogotá (Colombia).
Inhibitory receptors on T cells
To separate peripheral blood mononuclear cells (PBMCs) by Ficoll-Hypaque gradient (Sigma-Aldrich, St. Louis, MO, USA), approximately 15 ml of peripheral blood was obtained from all individuals by venipuncture with heparinized tubes. To evaluate the expression on inhibitory receptors on CD4+ and CD8+ T cells, PBMCs were adjusted to 1 x 10 6 PBMCs per tube and stained with anti CD3-PECy5, anti CD4-APCH7, anti CD8-AF700, anti CD160-AF647, anti 2B4-FITC (BD Bioscience, San Diego, CA, USA), and anti PD1-FITC (BD Bioscience), for 30 minutes at 4 °C in darkness. Intracellular CTLA-4 was detected in PBMCs permeabilized and fixed with the commercial kit Citofix/ Citoperm (BD Bioscience) according to the manufacturer´s instructions and stained with anti CTLA-4-APC (BD Bioscience) during 30 minutes at 4 °C in darkness. At least 50,000 CD8+ T cells were acquired for the analysis by using FacsAria I flow cytometer (BD Immunocytometry Systems, San Jose, CA, USA), in all cases a greater number of CD4+ T cells was acquired. The fluorescence minus one (FMO), was used to determine potential interference of the fluorochromes panel and as a negative control of marker expression. The data files were analyzed using FlowJo 7.6.1 software (Tree Star. Inc. Ashland, OR, USA).
Statistical analysis
A descriptive analysis of data, including the frequency of CD4+ and CD8+ T cells expressing the inhibitory receptors was carried out. The values were expressed as medians and ranges. The Mann-Whitney U test was used to determine differences among groups and differences were considered significant when p<0.05 using the GraphPad Prism 5.0 Statistical software (GraphPad Software, Inc, La Jolla, CA, USA).
Results
Expression of inhibitory receptors on CD4+ and CD8+ T cells
The expression of the inhibitory receptors was measured on T cells. The cells were selected based on the presence of unclustered singlets according to the size and complexity parameters. On this last population, the CD3+CD4+ and CD3+CD8+ T cells were selected ( Figure 1A) and finally, the expression of CD160, 2B4, PD-1 and CTLA-4 was analyzed ( Figure 1B) . CD160 expression on CD4+ T cells ranged from 0.04% to 3.51% (median 0.35%), and from 4.38% to 42.9% (median 16.3%) on CD8+ T cells. A significant difference, p < 0.0001, was found when both populations were compared ( Figure  2A) . The expression of 2B4 on CD4+ and CD8+ T cells ranged from 0.16% to 4.54% (median 1.04%) and 0.74% to 67.2% (median 8.98%), respectively. A significant difference (p < 0.0001) was noted between both T cell subsets ( Figure  2B) . The expression of PD-1 was detected on CD4+, and CD8+ T cells with ranges from 0.28% to 4.6% (median 1.35%), and 0.33% to 21.1% (median 4.3%), respectively. A significant difference between CD4+, and CD8+ T cells (p < 0.0001) was observed ( Figure 2C) . Percentages of CD4+, and CD8+ T cells expressing intracellular CTLA-4 varied from 0.23% to 26.9% (median 1.57%), and from 0.29% to 4.18% (median 1.54%). No difference was detected between the frequency of CD4 and CD8 T cells expressing this marker (Figure 2D) . 
Co-expression of CD160/2B4 and CTLA-4/ PD-1 on CD4+ and CD8+T cells
Studies on chronic infections showed that the co-expression of two or more inhibitory receptors on CD4+, and CD8+ T cells is associated with a dysfunctional state of these cells (4, 6, 7) . In this study, the percentage of CD4+, and CD8+ T cells co-expressing CD160/2B4 was 0.18% (range 0.02% to 0.89%) and 4.02% (range 0.67% to 34.6%), respectively. There was a significant difference between T cells (p < 0.0001) (Figures 3A and 3B) . The co-expression of CTLA-4/PD-1 was 0.09% on CD4+ T cells (range 0.0% to 0.27%) and 0.2% (range 0.01% to 3.5%) on CD8+ T cells.
A significant difference of p < 0.02 was observed when both populations were compared ( Figure 3C ).
Discussion
T cells can express a wide variety of co-stimulatory molecules that regulate the initial activation, cell division, and the subsequent generation and maintenance of memory T cells. Nonetheless, these cells also express inhibitory receptors like CD160, 2B4, PD-1 and CTLA-4, which have been implicated in the progressive loss of effector functions. This phenomenon, termed cellular exhaustion, mainly occurs under conditions of pathogen persistence during chronic infections (8, 9) . The increased expression of inhibitory receptors on T cells has also been described in tumors and autoimmune diseases (1).
CD160 is a protein mainly expressed on the surface of cytotoxic CD8+ T cells and Natural Killer (NK) cells (10, 11) . In this study, it was found that the expression of CD160 on CD4+ T cells from healthy Colombian donors was lower (0.35%) compared to that reported (8%) in United States donors (11) . This difference could be explained by the fact that both populations are exposed to different environments and stimuli. Indeed, it was reported that CD160 is expressed on CD4+ memory T cells (CD45RA-CD45RO+), and CD4+ T cells that have been recently activated (CD45RA+CD45RO-), but it is only barely observed on CD4+ naive T cells (11) . On the other hand, the CD160 expression on CD8+ T cells from Colombian healthy donors was similar (16.3%) to that reported (19%) by Rey et al (2006) in French healthy individuals (13) .
Interestingly, 2B4 is a co-stimulatory molecule that can induce both positive and negative signals during the activation of T cells. 2B4 is found in NK cells, monocytes and basophils (12, 13) . In contrast to the expression on CD4+ T cells, in this study the percentage of 2B4 expression on CD8+ T cells was highly variable among individuals with values ranging from 0.74% to 67.2%; similar to other reports in which percentages from 37% to 79% were described (13) . This marker is more detectable on differentiated CD8+ T cells than in naive T cells (14) .
PD-1, a protein from the immunoglobulin superfamily, is expressed on naive and activated T cells (7, 15, 16) . This molecule interacts with PD-L1 and PD-L2 ligands and helps to modulate T cell activation and to limit the duration of the adaptive cellular immune responses (15) . Similar to our results (4.3%), Song et al., reported frequencies of PD-1 expression on CD8+ T cells of 3.5% (17) whereas, Sachdeva et al., reported higher frequencies (7.4%) in healthy donors (1).
During Human Immunodeficiency Virus (HIV) infection, viral specific T cells showed a decreased expression of CD160, and 2B4 on CD4+ T cells compared to CD8+ T cells (18) . Likewise, our results indicated differences in CD160, 2B4, and PD-1 expression between CD4+ and CD8+ T cells suggesting that the mechanisms by which both T cell subsets gradually lose their functional capacity are different (18) .
CTLA-4 is a glycoprotein of the family of CD28 costimulatory molecules, which negatively regulates T cell activation. This molecule has been involved in immune regulation during bacterial and parasitic infections (19) (20) (21) (22) . Here, it was found that the frequency of CTLA-4 expression on CD4+ and CD8+ T cells was similar and consistent with previous reports, showing percentages from 1.95% to 2.40% (23) on CD4+, and of 2.9% on CD8+ T cells (24) .
The co-expression of inhibitory molecules seems critical to induce a dysfunctional state of T cells. In fact, it was observed that cytotoxic cells that express CD160 are mostly found in the 2B4+CD8+ T cell subpopulation (13) . Nevertheless, our results showed that the percentages of CD160 and 2B4 coexpression on CD4+ and CD8+ T cells were lower (0.18% and 4.02%) with respect to those reported in the literature (up to 27%) [13] . Likewise, the co-expression of CTLA-4/PD-1 on CD4+, and CD8+ T cells was low (0.09% and 0.2%); so far, there have been no reports of co-expression of these molecules in healthy individuals.
Studies of inhibitory receptor expression on T cells have been carried out on antigen-specific CD8+ T cells from patients with chronic viral infections coming from different countries (USA, France and Brazil) (11, 13) . Baitsch et al. showed that the analysis of co-expression patterns of inhibitory receptors increases with T cell differentiation, and also depends on antigen-specificity, and the differentiation and anatomical location of the T cells (25) . Aditionally, the differences found here could be explained by the fact that populations are exposed to different environments and stimuli.
Conclusions
Our work is the first report showing the frequency of inhibitory receptors like CD160, 2B4, PD-1 and CTLA-4 on CD4+ and CD8+ T cells from healthy Colombian population. This finding represents a base line for the analysis and comparison of the expression of receptors in Colombian populations with different disease conditions. received support from the Vicerrectoria de Investigaciones, Universidad de los Andes.
